Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers associated with the complete pathological response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancer.
Miolo G, Muraro E, Caruso D, Crivellari D, Ash A, Scalone S, Lombardi D, Rizzolio F, Giordano A, Corona G. Miolo G, et al. Among authors: muraro e. Oncotarget. 2016 Jun 28;7(26):39809-39822. doi: 10.18632/oncotarget.9489. Oncotarget. 2016. PMID: 27223427 Free PMC article.
A different immunologic profile characterizes patients with HER-2-overexpressing and HER-2-negative locally advanced breast cancer: implications for immune-based therapies.
Muraro E, Martorelli D, Turchet E, Miolo G, Scalone S, Comaro E, Talamini R, Mastorci K, Lombardi D, Perin T, Carbone A, Veronesi A, Crivellari D, Dolcetti R. Muraro E, et al. Breast Cancer Res. 2011;13(6):R117. doi: 10.1186/bcr3060. Breast Cancer Res. 2011. PMID: 22112244 Free PMC article.
Anthracycline-free neoadjuvant therapy induces pathological complete responses by exploiting immune proficiency in HER2+ breast cancer patients.
Miolo G, Muraro E, Martorelli D, Lombardi D, Scalone S, Spazzapan S, Massarut S, Perin T, Viel E, Comaro E, Talamini R, Bidoli E, Turchet E, Crivellari D, Dolcetti R. Miolo G, et al. Among authors: muraro e. BMC Cancer. 2014 Dec 15;14:954. doi: 10.1186/1471-2407-14-954. BMC Cancer. 2014. PMID: 25512030 Free PMC article. Clinical Trial.
Improved Natural Killer cell activity and retained anti-tumor CD8(+) T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapy.
Muraro E, Comaro E, Talamini R, Turchet E, Miolo G, Scalone S, Militello L, Lombardi D, Spazzapan S, Perin T, Massarut S, Crivellari D, Dolcetti R, Martorelli D. Muraro E, et al. J Transl Med. 2015 Jun 27;13:204. doi: 10.1186/s12967-015-0567-0. J Transl Med. 2015. PMID: 26116238 Free PMC article. Clinical Trial.
Emerging Role of Immunomonitoring to Predict the Clinical Outcome of Patients With Malignant Pleural Mesothelioma Treated With Radical Radiation Therapy.
Cangemi M, Montico M, Trovo M, Minatel E, Di Gregorio E, Corona G, Giordari F, Comaro E, Colizzi F, Baboçi L, Steffan A, Revelant A, Muraro E. Cangemi M, et al. Among authors: muraro e. Int J Radiat Oncol Biol Phys. 2023 Mar 1;115(3):608-621. doi: 10.1016/j.ijrobp.2022.09.079. Epub 2022 Oct 3. Int J Radiat Oncol Biol Phys. 2023. PMID: 36202181
54 results